← Back to Search

FAIR Program for Substance Use Disorders (PRE-FAIR Trial)

N/A
Recruiting
Led By Lisa Saldana, PhD
Research Sponsored by Chestnut Health Systems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 16 to 30 at date of intake assessment
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of study, up to 4 years
Awards & highlights

Summary

This trial offers the potential to deliver a new outpatient prevention program to high-risk, young parents in order to help address the opioid and methamphetamine use disorders crisis in Oregon.

Who is the study for?
This trial is for young parents aged 16 to 30 in Oregon who are at risk for opioid or methamphetamine addiction and have a child or a plan to reunite with their child. They must not have misused opioids or used meth more than three times last year, be involved with DHS, and live in a participating county.Check my eligibility
What is being tested?
The study compares the FAIR program—a community-based prevention service including mental health and parenting support—with standard case management for preventing substance misuse among high-risk parents. It will involve 240 participants randomized into two groups across two counties.See study design
What are the potential side effects?
Since this trial involves social services rather than medical treatments, traditional side effects like those seen with medications are not applicable. However, there may be emotional or psychological impacts from participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 16 and 30 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of study, up to 4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of study, up to 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Completion of Key Intervention Implementation Activities Over the Course of the Study
Costs Associated with Key Intervention Implementation Activities Over the Course of the Study
Mean Changes From Baseline in Parenting Behaviors as Assessed by the BCAP at 24-months Post-Baseline
+10 more
Secondary outcome measures
Descriptive Measures of FAIR Program Delivery
Mean Levels of Client Satisfaction with Services at the End of Treatment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pre-FAIRExperimental Treatment1 Intervention
Participants in this arm will receive the FAIR intervention.
Group II: ControlActive Control1 Intervention
Participants in this arm will receive services standard case management and services .

Find a Location

Who is running the clinical trial?

Chestnut Health SystemsLead Sponsor
22 Previous Clinical Trials
23,173 Total Patients Enrolled
Oregon Social Learning CenterLead Sponsor
35 Previous Clinical Trials
10,535 Total Patients Enrolled
Lisa Saldana, PhDPrincipal InvestigatorOregon Social Learning Center
3 Previous Clinical Trials
966 Total Patients Enrolled

Media Library

Families Actively Improving Relationships (FAIR) Clinical Trial Eligibility Overview. Trial Name: NCT05380440 — N/A
Opioid Use Disorder Research Study Groups: Pre-FAIR, Control
Opioid Use Disorder Clinical Trial 2023: Families Actively Improving Relationships (FAIR) Highlights & Side Effects. Trial Name: NCT05380440 — N/A
Families Actively Improving Relationships (FAIR) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05380440 — N/A
Opioid Use Disorder Patient Testimony for trial: Trial Name: NCT05380440 — N/A
~62 spots leftby Aug 2025